Related Experiment Videos
[Validation of a diagnostic kit for factor V Leiden mutation]
S Gandrille1, V Remones, M Aiach
1Centre technique d'hémostase, Hôpital européen Georges Pompidou, 20, rue Leblanc, 75908 Paris. sophie.gandrille@hop.egp.ap-hop-paris.fr
Annales De Biologie Clinique
|January 9, 2004
Summary
The Stagen kit accurately identifies the Factor V Leiden mutation using allele-specific amplification. This reliable method is suitable for hospital and private labs, simplifying thrombophilia testing.
Area of Science:
- Genetics
- Molecular Diagnostics
- Thrombophilia
Background:
- Factor V Leiden mutation is a common genetic risk factor for venous thromboembolism.
- Accurate and rapid identification of this mutation is crucial for patient management.
- Existing diagnostic methods may require multiple steps or specialized equipment.
Purpose of the Study:
- To evaluate the Stagen kit for identifying the Factor V Leiden mutation.
- To assess the kit's analytical performance and clinical utility.
- To determine the kit's reliability, specificity, and sensitivity.
Main Methods:
- The Stagen kit utilizes allele-specific amplification for Factor V Leiden mutation detection.
- The process includes DNA extraction from blood samples and electrophoresis of amplification products.
- Analytical properties were assessed, followed by a prospective study on 300 thrombophilic patients.
Main Results:
- The kit demonstrated robust analytical properties.
- The prospective study confirmed high specificity and sensitivity in identifying the Factor V Leiden mutation.
- Built-in controls minimize the risk of errors, ensuring high reliability.
Conclusions:
- The Stagen kit provides an easy, rapid, and reliable method for Factor V Leiden mutation detection.
- It is well-suited for both hospital and private laboratories, including those processing small patient series.
- This kit simplifies thrombophilia diagnostics and can aid in clinical decision-making.